IntelliGuard Appoints Robert Howard as CEO and Thomas Koning as President to Execute on Strategy of Continued Growth

IntelliGuard, provider of medication and inventory management solutions, today announces the appointments of Robert Howard as Chief Executive Officer (CEO) and Thomas Konin as President. The expansion of IntelliGuard’s executive team is part of the company’s mission to better serve the healthcare industry by enabling more efficient and effective systems to track, trace, and manage medications and critical inventory. Howard and Koning step into the leadership roles as Gordon Krass retires after serving as IntelliGuard CEO and President since 2017, during which time he helped to innovate workflow automation solutions to positively impact the efficiency, revenue, and safety of client partners.

Howard joined IntelliGuard in September 2022 as a member of the Board of Directors. As CEO, he will facilitate interactions and key operative decisions between the Board of Directors and the IntelliGuard leadership team. In his new position, Howard will focus on increasing market share, expanding IntelliGuard’s brand recognition, and simplifying industry adoption of IntelliGuard’s portfolio of solutions for medication data intelligence and integrity.

“IntelliGuard’s growth represents an evolution for our company and the industry in general,” said Howard. “I am privileged to be a part of our commitment to ensure global compliance toward maintaining patient safety. We have been successfully leveraging renewed and robust financial investment to support our RFID-enabled technology to track, trace, and manage medications and critical inventory.”

Koning joined IntelliGuard in December 2022 as Chief Revenue Officer. As IntelliGuard’s President, he will be responsible for establishing and maintaining strong industry and partner relationships and creating solutions that provide value and ultimately improve patient safety. Koning has more than 35 years of experience with startups and Fortune 500 companies in the healthcare and medical device industries. He served as Vice President of Sales for Europe and North America at Becton, Dickinson and Company (BD), prior to joining IntelliGuard.

“I see my role as an exciting opportunity to support and guide IntelliGuard on its trajectory of growth and service to the healthcare industry,” said Koning. “We will continue to build on the great success we are experiencing in delivering automation and intelligence to the medication management marketplace,” he added.

The IntelliGuard leadership team was first expanded in November 2022 with the appointment of Tim Tinnell as Chief Operating Officer (COO). He joined IntelliGuard in 2019 as the Chief Customer Officer (CCO), where he was responsible for overseeing implementations, customer support, and the overall customer experience.

Earlier this summer, IntelliGuard relocated its corporate headquarters from Carlsbad, CA, to San Diego, to accommodate its growing staff across all departments. As pharmaceutical manufacturers increasingly apply RFID Smart Labels in compliance with global standards, IntelliGuard is uniquely positioned to support a broad category of medications, critical inventory, and supplies. Specifically focused on solutions that serve hospital pharmacies, the Life Sciences consignment market, and the specialty medication market, IntelliGuard has been solving medication visibility challenges for more than 15 years.

Other Executives In the News

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy